Literature DB >> 21505313

Seroincidence of 2009 H1N1 infection in HIV-infected and HIV-uninfected women prior to vaccine availability.

Keri N Althoff1, Maryna Eichelberger, Stephen J Gange, Gerald B Sharp, Jin Gao, Marshall J Glesby, Mary Young, Ruth M Greenblatt, Audrey L French, Maria C Villacres, Howard Minkoff.   

Abstract

The 2009 H1N1 pandemic was a unique opportunity to investigate differences in influenza infection using serology by HIV status. Using serial serum specimens collected from 1 April to 30 September 2009 and the prior 2 years from Women's Interagency HIV study participants, there was no difference in serologic evidence of 2009 H1N1 infection among HIV-infected women with a CD4 cell count at least 350 cells/μl compared with HIV-uninfected women. Owing to evidence showing a greater risk of influenza-related complications, HIV-infected individuals should continue to be a priority group for vaccination.

Entities:  

Mesh:

Year:  2011        PMID: 21505313      PMCID: PMC3442364          DOI: 10.1097/QAD.0b013e3283471cf2

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  18 in total

Review 1.  The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench.

Authors:  Melanie C Bacon; Viktor von Wyl; Christine Alden; Gerald Sharp; Esther Robison; Nancy Hessol; Stephen Gange; Yvonne Barranday; Susan Holman; Kathleen Weber; Mary A Young
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

2.  Susceptibility to influenza A in HIV-positive patients.

Authors:  J P Cohen; C Macauley
Journal:  JAMA       Date:  1989-01-13       Impact factor: 56.272

3.  Influenza A among patients with human immunodeficiency virus: an outbreak of infection at a residential facility in New York City.

Authors:  A D Fine; C B Bridges; A M De Guzman; L Glover; B Zeller; S J Wong; I Baker; H Regnery; K Fukuda
Journal:  Clin Infect Dis       Date:  2001-05-16       Impact factor: 9.079

4.  Influenza in human immunodeficiency virus-infected patients during the 1997-1998 influenza season.

Authors:  H M Radwan; S H Cheeseman; K K Lai; R T Ellison III
Journal:  Clin Infect Dis       Date:  2000-08       Impact factor: 9.079

5.  Influenza-associated morbidity and mortality in young and middle-aged women.

Authors:  K M Neuzil; G W Reed; E F Mitchel; M R Griffin
Journal:  JAMA       Date:  1999-03-10       Impact factor: 56.272

6.  The Women's Interagency HIV Study. WIHS Collaborative Study Group.

Authors:  S E Barkan; S L Melnick; S Preston-Martin; K Weber; L A Kalish; P Miotti; M Young; R Greenblatt; H Sacks; J Feldman
Journal:  Epidemiology       Date:  1998-03       Impact factor: 4.822

7.  Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza.

Authors:  Ted Ross; Shanta Zimmer; Don Burke; Corey Crevar; Donald Carter; James Stark; Brendan Giles; Richard Zimmerman; Stephen Ostroff; Bruce Lee
Journal:  PLoS Curr       Date:  2010-02-24

8.  Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.

Authors:  Elizabeth Miller; Katja Hoschler; Pia Hardelid; Elaine Stanford; Nick Andrews; Maria Zambon
Journal:  Lancet       Date:  2010-01-21       Impact factor: 79.321

9.  Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men.

Authors:  K L Huang; F L Ruben; C R Rinaldo; L Kingsley; D W Lyter; M Ho
Journal:  JAMA       Date:  1987-04-17       Impact factor: 56.272

10.  Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes.

Authors:  F P Kroon; J T van Dissel; J C de Jong; R van Furth
Journal:  AIDS       Date:  1994-04       Impact factor: 4.177

View more
  3 in total

1.  [Not Available].

Authors:  Mark Hull; Pierre Giguère; Marina Klein; Stephen Shafran; Alice Tseng; Pierre Côté; Marc Poliquin; Curtis Cooper
Journal:  Can J Infect Dis Med Microbiol       Date:  2014       Impact factor: 2.471

2.  CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core: Canadian guidelines for management and treatment of HIV/hepatitis C coinfection in adults.

Authors:  Mark Hull; Marina Klein; Stephen Shafran; Alice Tseng; Pierre Giguère; Pierre Côté; Marc Poliquin; Curtis Cooper
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

3.  Seroincidence of Influenza Among HIV-infected and HIV-uninfected Men During the 2009 H1N1 Influenza Pandemic, Bangkok, Thailand.

Authors:  Shikha Garg; Sonja J Olsen; Stefan Fernandez; Charung Muangchana; Kamonthip Rungrojcharoenkit; Prabda Prapasiri; Jacqueline M Katz; Marcel E Curlin; Robert V Gibbons; Timothy H Holtz; Anupong Chitwarakorn; Fatimah S Dawood
Journal:  Open Forum Infect Dis       Date:  2014-10-10       Impact factor: 3.835

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.